End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14,500 KRW | -0.89% | -0.21% | -3.59% |
May. 12 | Whan In Pharm Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
Jun. 29 | Whanin Pharmaceutical Co. Ltd.(KOSE:A016580) added to Russell Global Index | CI |
Sales 2024 * | 249B 185M | Sales 2025 * | 271B 202M | Capitalization | 222B 165M |
---|---|---|---|---|---|
Net income 2024 * | 28B 20.83M | Net income 2025 * | 30B 22.32M | EV / Sales 2024 * | 0.75 x |
Net cash position 2024 * | 35B 26.04M | Net cash position 2025 * | 43.3B 32.22M | EV / Sales 2025 * | 0.66 x |
P/E ratio 2024 * |
9.65
x | P/E ratio 2025 * |
8.87
x | Employees | 553 |
Yield 2024 * |
2.07% | Yield 2025 * |
2.07% | Free-Float | 59.11% |
1 day | -0.89% | ||
1 week | -0.21% | ||
Current month | +1.68% | ||
1 month | -1.16% | ||
3 months | -3.59% | ||
6 months | +4.17% | ||
Current year | -3.59% |
Managers | Title | Age | Since |
---|---|---|---|
Won-Bum Lee
CEO | Chief Executive Officer | 49 | 05-12-31 |
Kwang-Sik Lee
CEO | Chief Executive Officer | 76 | 78-05-31 |
Ho-Chul Shin
CTO | Chief Tech/Sci/R&D Officer | 51 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Kwang-Sik Lee
CEO | Chief Executive Officer | 76 | 78-05-31 |
Won-Bum Lee
CEO | Chief Executive Officer | 49 | 05-12-31 |
Kyung-Seok Cho
BRD | Director/Board Member | 50 | 16-03-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 14,500 | -0.89% | 19,313 |
24-03-27 | 14,630 | +0.21% | 9,195 |
24-03-26 | 14,600 | 0.00% | 15,483 |
24-03-25 | 14,600 | +0.27% | 16,506 |
24-03-22 | 14,560 | +0.21% | 10,918 |
End-of-day quote Korea S.E., March 27, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.59% | 164M | |
+28.67% | 46.63B | |
+19.30% | 22.49B | |
+20.11% | 14.49B | |
+0.55% | 12.98B | |
+46.16% | 12.16B | |
-2.44% | 7.69B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+7.80% | 5.15B |